½ÃÀ庸°í¼­
»óǰÄÚµå
1542880

¼¼°èÀÇ ÇコÄɾî¿ë VR/AR ±â¼ú ½ÃÀå(2024-2031³â)

Global VR/AR Technology for Healthcare Market - 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°³¿ä

¼¼°èÀÇ ÇコÄɾî¿ë VR/AR ±â¼ú ½ÃÀåÀº 2023³â¿¡ 37¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç,2024-2031³â ¿¹Ãø ±â°£ Áß 15.8%ÀÇ CAGR·Î ¼ºÀåÇϸç, 2031³â¿¡´Â 121¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·áºÐ¾ßÀÇ Áõ°­Çö½Ç(AR)Àº µðÁöÅÐ Á¤º¸¿Í ¹°¸®Àû ȯ°æÀÇ À¶ÇÕÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Áø´Ü, ¼ö¼ú ¹× ȯÀÚ Ä¡·á Áß¿¡ ¹®¸Æ¿¡ ¸Â´Â µ¥ÀÌÅÍ¿Í 3Â÷¿ø ½Ã°¢È­¸¦ Á¦°øÇÏ¿© ÀÇ·á Á¾»çÀÚ¸¦ Áö¿øÇÏ¿© ÀÇ»ç °áÁ¤ ¹× ÀÇ·á °³ÀÔÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

°¡»óÇö½Ç(VR)Àº »ç¿ëÀÚ¸¦ ¿ÏÀüÈ÷ ½Ã¹Ä·¹ÀÌ¼ÇµÈ µðÁöÅРȯ°æ¿¡ ¸ôÀÔÇÏ°Ô ÇÕ´Ï´Ù. ÇコÄÉ¾î ¾÷°è´Â ÀÇ·á ±³À°, Ä¡·á, ȯÀÚ Âü¿©µµ Çâ»ó µî ´Ù¾çÇÑ ¸ñÀûÀ¸·Î VRÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº »ç½ÇÀûÀÎ ½Ã¹Ä·¹À̼ÇÀ» ÅëÇØ ±³À° °æÇè°ú Ä¡·á °á°ú¸¦ ¸ðµÎ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â AR/VRÀ» ¼º°øÀûÀ¸·Î ÅëÇÕÇϱâ À§Çؼ­´Â ¿øÈ°ÇÑ µµÀÔ°ú ÃÖÀûÀÇ ¼º´ÉÀ» º¸ÀåÇØ¾ß ÇÕ´Ï´Ù. AR/VR ±â¼úÀ» ÅëÇÑ Åë½ÅÀº Áß¿äÇÑ ÀÇ·á ÀýÂ÷°¡ ÁߴܵǴ °ÍÀ» ¹æÁöÇϱâ À§ÇØ °ß°íÇÏ°í ¾ÈÁ¤ÀûÀÎ ³×Æ®¿öÅ© ÀÎÇÁ¶ó°¡ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÃËÁø¿äÀÎ

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ AR/VR ±â¼ú Ȱ¿ëµµ Áõ°¡

¼¼°è ÇコÄɾî VR/AR ±â¼ú ½ÃÀå ¼ö¿ä´Â ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ AR/VR ±â¼úÀÇ È°¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾÷°è³» ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ÀÌ·¯ÇÑ ±â¼úÀÇ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß´Â Ã·´Ü ÀÇ·á±â±â¿Í ÇÔ²² Áõ°­Çö½Ç(AR) ¹× °¡»óÇö½Ç(VR) ±â¼úÀÇ ÅëÇÕÀ¸·Î Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÇöÀç ¼ö¼ú ¹× ¼ö¼ú Àü °èȹ ¹× Ž»ö, ½ÇÁ¦ ¼ö¼ú Àü ½Ã¹Ä·¹À̼Ç, º¹ÀâÇÑ ÇØºÎÇÐÀû ±¸Á¶ÀÇ ½Ã°¢È­¸¦ ÅëÇØ ¼ö¼ú Áß ¿Ü°úÀǻ縦 Áö¿øÇÏ´Â µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ AR°ú VRÀº ¹°¸®Ä¡·á, ÀçȰġ·á, ȯÀÚÀÇ ¸¸¼ºÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇÑ ¸ñÀûÀ¸·Îµµ Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, AR/VR ±â¼úÀ» µµÀÔÇÒ ¶§ ÀÇ·á Àü¹®°¡´Â È¿°úÀûÀÎ ÅëÇÕÀ» À§ÇÑ ±â¼úÀû ¿ä±¸»çÇ×°ú ÇÔ²² Áø·á ¹× ȯÀÚ ÇýÅÃÀÇ ±ÕÇüÀ» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù.

Àü ¼¼°è ÀÇ·á±â°ü°ú º´¿ø¿¡¼­´Â ÀÇ·á ±³À°, ¿¬±¸, Áúº´ Áø´Ü, ȯÀÚ Ä¡·á µî ´Ù¾çÇÑ ¸ñÀûÀ¸·Î AR°ú VR ±â¼úÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ º¹°­°æ ¼ö¼ú, ¹«¸­ Àΰø°üÀý ġȯ¼ú µîÀÇ ±³À°¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î ÀÇ·á ½Ã¹Ä·¹ÀÌ¼Ç Àü¹® ÀÇ·á ±â¼ú ±â¾÷ MediSim VRÀº 2022³â 6¿ù ǪµÎü¸® Àǰú ´ëÇÐ(PIMS)¿¡ Àεµ ÃÖÃÊÀÇ ¿ÏÀü ÀÚµ¿È­µÈ °¡»óÇö½Ç(VR) ½ÇÇè½ÇÀ» ¼³¸³Çß½À´Ï´Ù. ÀÌ ½ÇÇè½ÇÀº MBBS ÇлýµéÀÌ ÇʼöÀûÀÎ ÀÇ·á ±â¼úÀ» Çâ»ó½Ã۰í ÀÌ ºÐ¾ßÀÇ ¹Ì·¡ µµÀü¿¡ ´ëºñÇÒ ¼ö ÀÖµµ·Ï µ½±â À§ÇØ ¼³¸³µÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ÆÄÆ®³Ê½Ê ¹× Á¦ÈÞ¿Í °°Àº ÁÖ¿ä ±â¾÷ÀÇ Àü·«ÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 3¿ù IIT ¸¶µå¶ó½º ÇÁ¶ó¹ÙŹ Å×Å©³î·¯Áö½º Àç´Ü(IIT Madras Pravartak Technologies Foundation)Àº AR/VR/MR ±â¼ú Àü¹® ¼¼°è ±â¾÷ VyVoxel International Firm°ú Çù·ÂÇÏ¿© AR/VR ÇÁ·Î±×·¡¹Ö¿¡ °üÇÑ Á¾ÇÕÀûÀÎ °úÁ¤À» ½ÃÀÛÇÏ¿´½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥Àº ÇлýµéÀÌ ºü¸£°Ô ¹ßÀüÇÏ´Â Áõ°­Çö½Ç(AR) ¹× °¡»óÇö½Ç(VR) ºÐ¾ß¿¡ ÇÊ¿äÇÑ ±â¼úÀ» ½ÀµæÇϰí ÀÌ ºÐ¾ß¿¡¼­ ¹ßÀüÇÏ´Â µ¥ ÇÊ¿äÇÑ Àü¹® Áö½ÄÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ

°í°¡ÀÇ Ä¡·áºñ, Á¦ÇÑµÈ º¸±Þ·ü°ú ÀνÄ, »çÀ̹ö º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£ À§Çù, À±¸®Àû ¹× ¹ýÀû ¹®Á¦, Æò°¡ Åø ºÎÁ·, Ç¥ÁØÈ­ ºÎÁ· µîÀÇ ¿äÀÎÀÌ ½ÃÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¼¼°èÀÇ ÇコÄɾî¿ë VR/AR ±â¼ú ½ÃÀåÀº ÄÄÆ÷³ÍÆ®, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù.

Áõ°­Çö½Ç ºÎ¹®Àº ¼¼°èÀÇ ÇコÄɾî¿ë VR/AR ±â¼ú ½ÃÀå Á¡À¯À²ÀÇ ¾à 59.4%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß Áõ°­Çö½Ç(AR) ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áõ°­Çö½Ç(AR) ±â¼úÀº µðÁöÅÐ À̹ÌÁö¿Í Á¤º¸¸¦ »ç¿ëÀÚÀÇ ½ÇÁ¦ ÁÖº¯ ȯ°æ¿¡ °ãÃļ­ Çö½Ç ¼¼°è¸¦ º¸¿ÏÇÏ´Â °¡»ó ·¹À̾ »ý¼ºÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌ ¾÷°èÀÇ ÁÖ¿ä ¾÷üµéÀº ÇコÄÉ¾î »ê¾÷¿¡ ±â¼úÀ» ÅëÇÕÇϰí ÀÌ ½ÃÀåÀÇ ÀÌ ºÎ¹®À» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ȯÀÚ Ä¡·áÀÇ ÁÖ¿ä ¹ßÀü¿¡ ´õ ¸¹Àº ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 2¿ù ½ºÅÄÆ÷µå ÀÇ´ë ÀÇ»ç¿Í »ý¹° ÀÇÇÐ ¿£Áö´Ï¾î ÆÀÀº ¼ö¼ú¿¡ »õ·Î¿î Áõ°­Çö½Ç(AR) ÅøÀ» µµÀÔÇØ ¼±±¸ÀÚ ¿ªÇÒÀ» Çß½À´Ï´Ù. ¾ÖÇà ºñÀü ÇÁ·Î¶ó°í ºÒ¸®´Â ÀÌ ±â¼úÀº Àΰ£°ú ÄÄÇ»ÅÍÀÇ »óÈ£ ÀÛ¿ëÀ» °­È­ÇÏ´Â Çìµå¼ÂÀ¸·Î, »ç¿ëÀÚ´Â ½Ç½Ã°£ ½Ã°¢ Á¤º¸¿Í °¡»ó ÄÄÆ÷³ÍÆ®¸¦ À¶ÇÕÇÏ¿© ÁÖº¯ ȯ°æÀ» Ž»öÇÒ ¼ö ÀÖ½À´Ï´Ù.

2023³â 6¿ù, Àεµ °íÄ¡ÀÇ ¾Ï¸®Å¸ º´¿ø(Amrita Hospital)Àº ÇコÄÉ¾î ºÐ¾ßÀÇ È¹±âÀûÀÎ Áõ°­Çö½Ç(XR) »ýŰ踦 °³¹ßÇϱâ À§ÇØ ¾Õ¼­¼­ Ãâ¹ßÇß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ½Ã½ºÅÛÀº Áõ°­Çö½Ç(AR), °¡»óÇö½Ç(VR), È¥ÇÕÇö½Ç(MR) ±â¼úÀÇ ÈûÀ» Ȱ¿ëÇÏ¿© ȯÀÚ Ä¡·á, ÀÇ·á ÈÆ·Ã ¹× ¿¬±¸ ¿ª·®À» Å©°Ô Çâ»ó½Ãų °ÍÀÔ´Ï´Ù. ÀÌ Ã·´Ü ±â¼úÀÇ ÀÓ»ó ÅëÇÕÀº Àεµ ÀÇ·á »ê¾÷¿¡¼­ Áß¿äÇÑ ÀÌÁ¤Ç¥ÀÌÀÚ È¹±âÀûÀÎ µµ¾àÀ» ÀǹÌÇÏ´Â Áß¿äÇÑ ÀÌÁ¤Ç¥ÀÔ´Ï´Ù.

¶ÇÇÑ ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ, ±â¼ú ¹ßÀü°ú °°Àº ÁÖ¿ä ±â¾÷ÀÇ Àü·«ÀÌ ÀÌ ºÐ¾ß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 12¿ù, ±³À° ¹× »ê¾÷À» À§ÇÑ Áõ°­Çö½Ç(Augmented Reality) ¹× °¡»óÇö½Ç(Virtual Reality) °æÇèÀ» âÃâÇÏ´Â ¼¼°è ¸®´õÀÎ EON Reality´Â ¿À·»Áö Ä«¿îƼ ¾î¸°ÀÌ º´¿ø(Children's Hospital of Orange County(CHOC)¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» °»½ÅÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. À̹ø ÆÄÆ®³Ê½ÊÀº ¼Ò¾Æ ÀÇ·á ±³À°¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ȯÀÚ °æÇèÀ» °³¼±Çϱâ À§ÇØ Çõ½ÅÀûÀÎ AR/VR ±â¼úÀ» äÅÃÇÏ´Â µ¥ ´ëÇÑ ¾ç»çÀÇ »óÈ£ Çå½ÅÀ» °­Á¶ÇÏ´Â °ÍÀÔ´Ï´Ù.

½ÃÀå Áö¿ª Á¡À¯À²

ºÏ¹Ì´Â ÇコÄɾî VR/AR ±â¼ú ¼¼°è ½ÃÀå Á¡À¯À²ÀÇ ¾à 44.6%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â AR/VR ±â¼ú äÅà Áõ°¡, ÁÖ¿ä R&D ÅõÀÚ, ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Á¤ºÎ ±¸»ó¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ÀÌ Áö¿ª¿¡¼­´Â ¸¹Àº ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó ¹× ±â¼ú ¹ßÀüÀÌ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù OrthoIndy´Â ¼ö¼ú¿¡ Áõ°­Çö½Ç(AR)À» µµÀÔÇÏ¿© ¼ö¼ú ±â¼ú Çõ½Å¿¡ Å« ÁøÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. À¯¸íÇÑ Ã´Ãß ¿Ü°ú ÀÇ»ç ±×·¹°í¸® ÆúÅÍ(Gregory Porter) ¹Ú»ç´Â Surgical TheaterÀÇ ÃÖ÷´Ü eXperiential Reality(XR) ±â¼úÀ» »ç¿ëÇÏ¿© Àεð¾Ö³ª ÁÖ¿¡¼­ óÀ½À¸·Î ôÃß ¼ö¼úÀ» ½ÃÇàÇß½À´Ï´Ù.

OrthoIndy´Â ÀÌ Ã·´Ü ¼ö¼ú¹ýÀ» äÅÃÇÑ ¼¼°è 5°÷ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ ¼±±¸ÀûÀΠôÃß °íÁ¤¼ú¿¡´Â Microsoft HoloLens Çìµå¼ÂÀ» ÅëÇÕÇÏ¿© ¼ö¼ú Áß Çâ»óµÈ ½Ã°¢Àû °æÇèÀ» Á¦°øÇÏ´Â Surgical Theater SyncAR Spine Ç÷§ÆûÀÌ »ç¿ëµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ 2024³â 4¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº '°Ç°­°ü¸® Çãºê·Î¼­ÀÇ °¡Á¤'À̶ó´Â »õ·Î¿î ±¸»óÀ» µµÀÔÇß½À´Ï´Ù. ÀÌ ±¸»óÀº Áõ°­Çö½Ç°ú °¡»óÇö½Ç ±â¼úÀ» Ȱ¿ëÇÏ¿© °¡Á¤À» ÀÇ·á ½Ã½ºÅÛÀÇ ÄÄÆ÷³ÍÆ®·Î À籸¼ºÇÏ¿© °Ç°­ ÇüÆò¼ºÀ» ³ôÀÌ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀüȯÀ» ÃËÁøÇϱâ À§ÇØ FDA´Â °Ç°­¿¡ ÃÊÁ¡À» ¸ÂÃá °Ç¹° ¼³°è¸¦ Àü¹®À¸·Î ÇÏ´Â °ÇÃà ȸ»ç¿Í °è¾àÀ» ¸Î°í °¡Á¤À» ÇコÄɾî ȯ°æÀ¸·Î ÀüȯÇÏ´Â µ¥ ÇÊ¿äÇÑ »çÇ×À» Æò°¡Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ÇコÄɾ¼­ AR/VR ±â¼úÀÇ ÀÌ¿ë È®´ë
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·áºñÀÇ »ó½Â
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®

Á¦6Àå ÄÄÆ÷³ÍÆ®º°

  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦7Àå ±â¼úº°

  • Áõ°­Çö½Ç
  • °¡»óÇö½Ç

Á¦8Àå ¿ëµµº°

  • ¼ö¼ú ¾ÖÇø®ÄÉÀ̼Ç
  • ½Ã¹Ä·¹À̼ǰú Áø´Ü
  • â»ó Ä¡·á °ü¸®
  • ¹°¸® Ä¡·á¿Í ÀçȰ
  • Æ®·¹À̴ס¤ÀÇ·á ±³À°
  • °¡»óÇö½Ç üÇè ¿ä¹ý(VRET)
  • ±âŸ

Á¦9Àå ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø¡¤Àü¹® Ŭ¸®´Ð
  • ¿Ü°ú Áø´Ü ¼¾ÅÍ
  • ±âŸ

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå ÇöȲ/Á¡À¯À² ºÐ¼®
  • M&A ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • F. Hoffmann-La Roche Ltd
    • ȸ»ç °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • CAE Inc.
  • EON Reality, Inc.
  • InfiVR Solutions
  • Vection Technologies
  • Siemens Healthcare S.A.E.
  • Fundamental Surgery
  • Koninklijke Philips N.V.
  • Novac Technology Solutions
  • Softeq Development Corp.(*LIST NOT EXHAUSTIVE)

Á¦13Àå ºÎ·Ï

KSA 24.09.06

Overview

The Global VR/AR Technology for Healthcare Market reached US$ 3.75 billion in 2023 and is expected to reach US$ 12.14 billion by 2031 growing with a CAGR of 15.8% during the forecast period 2024-2031.

Augmented Reality (AR) in healthcare refers to the combination of digital information with the physical environment. This technology supports healthcare professionals by delivering contextual data and three-dimensional visualizations during diagnoses, surgical procedures, and patient treatment, thereby improving decision-making and the precision of medical interventions.

Virtual Reality (VR) immerses users in entirely simulated digital environments. In the healthcare industry, VR is employed for a range of purposes, such as medical training, treatments, and enhancing patient engagement. This technology enables realistic simulations that enhance both educational experiences and treatment results.

However, for the successful integration of AR/VR in healthcare, providers must ensure smooth implementation and optimal performance. To prevent disruptions during critical medical procedures, communication via AR/VR technologies requires a robust and dependable network infrastructure.

Market Dynamics: Drivers

Increasing usage of AR/ VR technologies in healthcare

Multiple factors drive the demand for global VR/AR technology in the healthcare market. One of the primary factors driving the market is the increasing usage of AR/ VR technologies in healthcare and the expanding applications of these technologies across various domains within the industry.

The healthcare sector has undergone significant changes owing to the integration of augmented reality (AR) and virtual reality (VR) technologies alongside advanced medical devices. These technologies are currently utilized in a variety of medical applications, such as surgical and pre-surgical planning and navigation, simulating procedures before actual surgeries, and visualizing intricate anatomical structures to aid surgeons during operations.

Moreover, AR and VR are employed in physical therapy and rehabilitation, as well as in helping patients effectively manage chronic conditions. When implementing AR/VR technologies, healthcare professionals need to weigh the advantages for their practice and patients alongside the technological requirements necessary for effective integration.

Medical institutions and hospitals around the globe are increasingly adopting AR and VR technologies for various purposes, including medical training, research, disease diagnosis, patient care, and more. These technologies are particularly utilized in training for laparoscopic surgeries and procedures such as knee replacements.

For instance, in June 2022, MediSim VR, a med-tech company specializing in healthcare simulation, established India's first fully automated Virtual Reality (VR) lab at the Puducherry Institute of Medical Sciences (PIMS). This lab is designed for MBBS students to enhance their essential medical skills and prepare them for future challenges in the field.

In addition, key player strategies such as partnerships and collaborations help to drive this market growth. For instance, in March 2024, the IIT Madras Pravartak Technologies Foundation collaborated with VyVoxel International Firm, a global company specializing in AR/VR/MR technologies, to launch a comprehensive course on AR/VR programming. This program is designed to equip students with the necessary skills for the rapidly evolving fields of Augmented Reality (AR) and Virtual Reality (VR), providing them with the expertise needed to advance in this area.

Restraints

Factors such as the high cost of treatment, limited adoption & awareness among people, cybersecurity & privacy threats, ethical & legal concerns, lack of assessment tools, and lack of standardization are expected to hamper the market.

Market Segment Analysis

The global VR/AR technology for the healthcare market is segmented based on component, technology, application, end-user, and region.

The augmented reality segment accounted for approximately 59.4% of the global VR/AR technology for healthcare market share

The augmented reality segment is expected to hold the largest market share over the forecast period. Augmented Reality (AR) technology overlays digital images or information onto the user's actual surroundings, creating a virtual layer that complements the real world.

Moreover, key players in the industry more focus on incorporating technology into the healthcare industry and key developments in patient care that would help to drive this segment in the market. For instance, in February 2024, a team of doctors and biomedical engineers from Stanford Medicine became trailblazers by integrating a novel augmented reality tool into surgical practices. This technology, called Apple Vision Pro, is a headset that enhances human-computer interaction, allowing users to explore their surroundings by merging real-time visual information with virtual components.

Similarly, in June 2023, Amrita Hospital in Kochi, India, pioneered the development of a groundbreaking Extended Reality (XR) ecosystem in healthcare. This innovative system harnesses the power of augmented reality (AR), virtual reality (VR), and mixed reality (MR) technologies to significantly elevate patient care, medical training, and research capabilities. The integration of this cutting-edge technology into clinical practice represents a significant milestone in the Indian healthcare industry, marking a transformative leap forward.

In addition, key player's strategies such as partnerships & collaborations, and technological advancements drive this segment's growth in the market. For instance, in December 2023, EON Reality, a global leader in creating Augmented and Virtual Reality experiences for education and industry, proudly announced the renewal of its strategic partnership with the Children's Hospital of Orange County (CHOC). This collaboration emphasizes their mutual dedication to employing innovative AR/VR technologies to revolutionize pediatric healthcare education and improve the patient experience.

Market Geographical Share

North America accounted for approximately 44.6% of the global VR/AR technology for healthcare market share

North America region is expected to hold the largest market share over the forecast period owing to the increased adoption of AR/VR technologies, major R&D investments, and government initiatives driving this market growth in this region.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, and technological advancements would propel this market growth in this region. For instance, in April 2024, OrthoIndy made a significant advancement in surgical innovation by introducing augmented reality (AR) into its procedures. Dr. Gregory Poulter, a prominent spine surgeon, performed Indiana's first spinal surgery using Surgical Theater's state-of-the-art eXperiential Reality (XR) technology.

OrthoIndy is among only five locations worldwide employing this advanced method. The pioneering spinal fusion procedure utilized the Surgical Theater SyncAR Spine platform, which integrates Microsoft HoloLens headsets to provide an enhanced visual experience during surgery.

Also, in April 2024, the Food and Drug Administration (FDA) introduced a new initiative called Home as a Health Care Hub, which aims to utilize augmented reality and virtual reality technologies to enhance health equity by reimagining the home as a component of the healthcare system. To facilitate this transformation, the FDA has contracted an architectural firm that specializes in designing health-focused buildings to assess what is necessary to convert a home into a healthcare environment.

Market Segmentation

By Component

Hardware

Software

Services

By Technology

Augmented Reality

Virtual Reality

By Application

Surgical Applications

Simulation & Diagnostics

Wound Care Management

Physical Therapy & Rehabilitation

Training & Medical Education

Virtual Reality Exposure Therapy (VRET)

Others

By End-User

Hospitals & Specialty Clinics

Surgical Diagnostic Centers

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the VR/AR technology for healthcare market include F. Hoffmann-La Roche Ltd, CAE Inc., EON Reality, Inc., InfiVR Solutions, Vection Technologies, Siemens Healthcare S.A.E., Fundamental Surgery, Koninklijke Philips N.V., Novac Technology Solutions, and Softeq Development Corp. among others.

Key Developments

In March 2024, Siemens Healthineers launched an app tailored for the Apple Vision Pro, allowing users such as surgeons, medical students, and patients to explore immersive, interactive holograms of the human body derived from medical scans within their real-world surroundings. This app, Cinematic Reality, aims to aid in surgical planning, enhance medical education, and assist patients in visualizing upcoming procedures. It is now available for download on the Apple App Store.

In October 2023, Surgical Theater proudly announced a significant milestone in collaboration with Stanford Medicine-successfully executing the first spine surgery utilizing their augmented reality technology. This innovative procedure employed the Surgical Theater SyncAR Spine system, which integrates Microsoft HoloLens headsets to enhance the surgical experience.

Why Purchase the Report?

To visualize the global VR/AR technology for healthcare market segmentation based on component, technology, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the VR/AR technology for the healthcare market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global VR/AR technology for healthcare market report would provide approximately 70 tables, 65 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Usage of AR/ VR Technologies in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Augmented Reality *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Virtual Reality

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Surgical Applications *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Simulation & Diagnostics
  • 8.4. Wound Care Management
  • 8.5. Physical Therapy & Rehabilitation
  • 8.6. Training & Medical Education
  • 8.7. Virtual Reality Exposure Therapy (VRET)
  • 8.8. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Specialty Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Surgical Diagnostic Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. F. Hoffmann-La Roche Ltd *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. CAE Inc.
  • 12.3. EON Reality, Inc.
  • 12.4. InfiVR Solutions
  • 12.5. Vection Technologies
  • 12.6. Siemens Healthcare S.A.E.
  • 12.7. Fundamental Surgery
  • 12.8. Koninklijke Philips N.V.
  • 12.9. Novac Technology Solutions
  • 12.10. Softeq Development Corp. (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦